Walter & Keenan Financial Consulting Company Cut By $583,625 Its Johnson & Johnson (JNJ) Holding; Highfields Capital Management LP Has Increased Teva Pharmaceutical Inds LTD (TEVA) Position By $312.73 Million

August 18, 2017 - By Vivian Currie

Walter & Keenan Financial Consulting Company decreased Johnson & Johnson (JNJ) stake by 8.34% reported in 2016Q4 SEC filing. Walter & Keenan Financial Consulting Company sold 5,075 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Walter & Keenan Financial Consulting Company holds 55,805 shares with $6.43 million value, down from 60,880 last quarter. Johnson & Johnson now has $357.08 billion valuation. The stock decreased 0.84% or $1.13 during the last trading session, reaching $133.04. About shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since August 18, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Highfields Capital Management Lp increased Teva Pharmaceutical Inds Ltd (TEVA) stake by 106.19% reported in 2016Q4 SEC filing. Highfields Capital Management Lp acquired 8.69M shares as Teva Pharmaceutical Inds Ltd (TEVA)’s stock declined 15.11%. The Highfields Capital Management Lp holds 16.87 million shares with $611.45M value, up from 8.18 million last quarter. Teva Pharmaceutical Inds Ltd now has $17.65B valuation. The stock decreased 2.23% or $0.39 during the last trading session, reaching $17.1. About 6,539 shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since August 18, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Among 27 analysts covering Teva Pharma (NYSE:TEVA), 6 have Buy rating, 2 Sell and 19 Hold. Therefore 22% are positive. Teva Pharma had 83 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Credit Suisse to “Outperform” on Monday, October 31. The stock has “Neutral” rating by Mizuho on Friday, February 10. As per Tuesday, January 31, the company rating was upgraded by Bank of America. The rating was maintained by Maxim Group with “Hold” on Friday, August 4. Maxim Group maintained it with “Buy” rating and $49 target in Wednesday, January 4 report. Piper Jaffray maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) rating on Thursday, August 3. Piper Jaffray has “Hold” rating and $2300 target. The company was downgraded on Friday, August 4 by Cowen & Co. The stock has “Outperform” rating by Oppenheimer on Friday, September 2. The firm has “Neutral” rating given on Friday, January 20 by JP Morgan. The firm has “Buy” rating by Jefferies given on Thursday, July 14.

Highfields Capital Management Lp decreased Iac Interactivecorp (NASDAQ:IACI) stake by 219,719 shares to 4.22M valued at $273.17 million in 2016Q4. It also reduced American Tower Corp New (Call) (NYSE:AMT) stake by 3.33M shares and now owns 20,000 shares. Alphabet Inc was reduced too.

Since February 28, 2017, it had 0 insider buys, and 3 insider sales for $9.95 million activity. Kapusta Ronald A sold 14,543 shares worth $1.78M. $1.99M worth of Johnson & Johnson (NYSE:JNJ) shares were sold by Pruden Gary J. $6.18 million worth of Johnson & Johnson (NYSE:JNJ) was sold by Duato Joaquin on Friday, March 3.

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.12, from 0.82 in 2016Q3. It increased, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. Rocky Mountain Advisers Llc reported 1.27% of its portfolio in Johnson & Johnson (NYSE:JNJ). State Street Corporation reported 1.66% of its portfolio in Johnson & Johnson (NYSE:JNJ). Moreover, Midwest Management Limited Liability has 0.21% invested in Johnson & Johnson (NYSE:JNJ). Jensen Invest Mgmt invested in 4.54% or 2.69 million shares. Torray Ltd Com accumulated 1.39% or 113,486 shares. Santa Barbara Asset Management Ltd Liability Corporation holds 2.26% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 1.09 million shares. Delta Asset Management Lc Tn holds 0.48% or 25,072 shares in its portfolio. Brown Limited has invested 0% in Johnson & Johnson (NYSE:JNJ). Badgley Phelps Bell accumulated 116,914 shares. Peak Asset Mgmt holds 0.62% or 13,541 shares. Rench Wealth Management Incorporated reported 36,366 shares. Horizon Investments Ltd Liability Com holds 25,643 shares or 0.2% of its portfolio. Iowa Bancorporation, a Iowa-based fund reported 44,356 shares. 156,800 are owned by Intact Inv Mgmt. Moreover, Deltec Asset Mgmt has 0.09% invested in Johnson & Johnson (NYSE:JNJ) for 3,425 shares.

Among 22 analysts covering Johnson & Johnson (NYSE:JNJ), 10 have Buy rating, 4 Sell and 8 Hold. Therefore 45% are positive. Johnson & Johnson had 60 analyst reports since August 7, 2015 according to SRatingsIntel. Wells Fargo downgraded the shares of JNJ in report on Thursday, January 26 to “Market Perform” rating. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by S&P Research on Wednesday, October 14. The firm has “Buy” rating given on Wednesday, October 19 by UBS. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, August 25. Cowen & Co has “Outperform” rating and $114 target. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Monday, October 5 by Piper Jaffray. Jefferies maintained the stock with “Hold” rating in Thursday, August 4 report. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, January 25. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, October 7. RBC Capital Markets has “Outperform” rating and $114 target. The firm has “Buy” rating given on Monday, July 10 by BMO Capital Markets. Deutsche Bank upgraded Johnson & Johnson (NYSE:JNJ) on Tuesday, September 29 to “Buy” rating.

Walter & Keenan Financial Consulting Company increased Procter And Gamble Co (NYSE:PG) stake by 4,345 shares to 62,782 valued at $5.28M in 2016Q4. It also upped Microsoft Corp (NASDAQ:MSFT) stake by 9,000 shares and now owns 110,118 shares. Powershares Etf Tr Ii (VRP) was raised too.